Skip to main content
MedPathMedPath Home
Clinical Trials/TCTR20220415002
TCTR20220415002
Completed
Not Applicable

smartphone-derived biomarker for discriminating mild cognitive impairment

/A0 sites60 target enrollmentApril 15, 2022
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsMild cognitive impairmentmild cognitive impairmentkey strokeecological validated screeningbiomarker

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Mild cognitive impairment
Sponsor
/A
Enrollment
60
Status
Completed
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 15, 2022
End Date
October 31, 2023
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
/A

Eligibility Criteria

Inclusion Criteria

  • •(1\) a subjective memory complaint
  • •(2\) objective memory impairment confirmed by performances on the neuropsychological battery (Seoul Neuropsychological Screening Battery)
  • •(3\) intact global cognitive function confirmed by the Korean version of Mini\-Mental State Examination
  • •(4\) independent activities of daily living
  • •(5\) no dementia diagnosis confirmed by a physician

Exclusion Criteria

  • •(1\) the presence of psychiatric or neurological disorders
  • •(2\) the presence of auditory or visual impairments

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Video Vitals and BiomarkersCardiometabolic Diseases
NCT06136156Maiv Health Inc.237
Completed
Not Applicable
tilizing Smart Devices to Identify New Phenotypical Characteristics in Movement DisordersHealthy volunteersOther movement disorders including atypical Parkinsonian disordersG20G25.0Parkinson diseaseEssential tremor
DRKS00016594Innovative Medizinische Forschung Medizinische Fakultät MünsterWestfälische Wilhelms-Universität Münster513
Recruiting
Not Applicable
The search for biomarkers to enable detection and monitoring of disease progression from NAFLD to NASH and NASH itself; Amsterdam NASH cohort
NL-OMON52739Academisch Medisch Centrum300
Not yet recruiting
Not Applicable
The search for biomarkers to enable detection and monitoring of disease progression from NAFLD to NASH and NASH itself; the Amsterdam NASH cohort
NL-OMON19935Academic Medical Center (AMC), Amsterdam1,100
Completed
Not Applicable
Evaluation of a Smartphone Based Diagnostic Tool to Assess Neonatal Jaundice in a Mexican PopulationJaundice, Neonatal
NCT05623553Picterus AS174